상세 보기
Quality of Life Outcomes from the Phase 3 Study of Atezolizumab plus Bevacizumab and Chemotherapy (ATTLAS, KCSG-LU19-04) in EGFR/ALK-Mutated NSCLC
- Kang, E. J.;
- Park, S.;
- Kim, T. M.;
- Han, J-Y.;
- Lee, G-W.;
- ... Sun, J-M;
- ... Lee, S-H.;
- ... Ahn, J. S.;
- 외 16명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0키워드
Quality of Life; Non-small Cell Lung Cancer; Atezolizumab Bevacizumab
- 제목
- Quality of Life Outcomes from the Phase 3 Study of Atezolizumab plus Bevacizumab and Chemotherapy (ATTLAS, KCSG-LU19-04) in EGFR/ALK-Mutated NSCLC
- 저자
- Kang, E. J.; Park, S.; Kim, T. M.; Han, J-Y.; Lee, G-W.; Shim, B. Y.; Lee, Y-gG; Kim, S-W.; Kim, I. H.; Lee, S.; Kim, Y. J.; Park, J. H.; Park, S-g.; Lee, K. H.; Kim, J. W.; Shin, S-H.; Nam, B-H. N.; Ock, C-Y; Lee, J.; Jung, H. A.; Sun, J-M; Lee, S-H.; Ahn, J. S.; Ahn, M-J
- 발행일
- 2025-10
- 유형
- Meeting Abstract
- 권
- 20
- 호
- 10